Supplementary protection
LT - Dapoksetino, greitos pradžios serotinino selektyvaus grįžtamojo pateikimo slopintojo, panaudojimas seksualinio sutrikimo gydymui
EN - THE USE OF DAPOXETINE, A RAPID-ONSET SELECTIVE SEROTONIN REUPTAKE INHIBITOR, FOR TREATING SEXUAL DYSFUNCTION
SPC
| (11) |
Number of the document |
C 1225881 |
| (68) |
Number of the document |
1225881
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2012 018 |
| (22) |
Date of filing the application |
2012-10-09 |
| (41) |
Date of publication of the application |
2012-11-26 |
|
Date of publication of SPC |
2014-01-27 |
| (24) |
Date of coming into effect of SPC |
2020-08-23 |
Applicant
| (71) |
APBI Holdings, LLC,
,
|
Grantee
| (73) |
Allergan Sales, LLC,
2525 Dupont Drive, Irvine, CA 92612,
US
|
Attorney or representative
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
Number and date of the first national authorization to place the medicinal or plant protection product on the market
| (92) |
LT/1/12/2920/001 - LT/1/12/2920/004, 2012 04 27 LT/1/12/2920/005 - LT/1/12/2920/008, 2012-04-27
|
Calculated date of expiry of the SPC
| (94) |
2024-02-06 |
Name of the product protected by the basic patent
| (95) |
Dapoxetinum |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-07-31 |
|
347.00
EUR
|
